WELL Health Technologies (TSE:WELL) Price Target Raised to C$11.00

WELL Health Technologies (TSE:WELL) had its price objective raised by Raymond James from C$10.00 to C$11.00 in a research report sent to investors on Tuesday,BayStreet.CA reports.

WELL has been the topic of a number of other research reports. TD Securities raised their price target on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday. Scotiabank raised their target price on shares of WELL Health Technologies from C$6.00 to C$7.00 in a report on Monday. CIBC upped their price target on shares of WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday, December 13th. Ventum Financial reduced their price target on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th. Finally, Haywood Securities upped their target price on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th.

WELL Health Technologies Trading Up 0.3 %

Shares of WELL stock opened at C$7.02 on Tuesday. WELL Health Technologies has a 12-month low of C$3.41 and a 12-month high of C$7.19. The firm has a 50 day moving average price of C$5.35 and a two-hundred day moving average price of C$4.78. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. The company has a market capitalization of C$1.75 billion, a PE ratio of 12.32, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.